5% Lidocaine Ointment in the Treatment of Vulvar Vestibulitis

Stopped early · Phase 2 · Has a placebo group

Conditions studied: Vulvar Vestibulitis

In brief

* Study Hypothesis: Use of 5% topical lidocaine ointment will result in improved ability to have sexual intercourse and decreased pain scores in women with vestibulitis when compared to placebo. * This is a study to assess if topical lidocaine will improve symptoms in women with vulvar vestibulitis. It compares use of nightly 5% topical lidocaine ointment to placebo ointment. The duration of the study is 8 weeks. 28 women will be in each arm for a total of 56 women in the study.

Key facts

Study ID

NCT00450242

Run by

University of North Carolina, Chapel Hill

People needed

14

Starts

2006-12-01

Expected to finish

2009-01-01

Last updated by the study team

2012-07-16

Who can join

Age: 18 and older, up to 50. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• women with the clinical diagnosis of vvs who have dyspareunia as their primary complaint. They must have a current sexual partner.

You may not qualify if…

• postmenopausal
• pure vaginismus
• generalized vulvodynia
• pudendal neuralgia
• pregnant, breastfeeding
• less than 2 months post delivery
• diagnosis of dermatologic condition on biopsy
• positive fungal culture
• currently on treatment for vvs
• history of lidocaine treatment for vvs

Where it is running

• University of North Carolina — Chapel Hill, North Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.